Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Wilson

Showing results (241-250 of 261) with videos related to

Pageof 27
Sort By:
The Journal of Clinical Investigation|June 4, 2014
Abnormal B cell memory subsets dominate HIV-specific responses in infected individualsLela Kardava, Susan Moir, Naisha Shah, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 23, 2012
Patient selection for oncology phase I trials: a multi-institutional study of prognostic factorsDavid Olmos, Roger P A'hern, Silvia Marsoni, et al.
NPJ Vaccines|August 20, 2025
Accelerated cGMP production of near-native HIV-1 Env trimers following electroporation transfection and immunogenicity analysisShridhar Bale, Elena Gustchina, Javier Guenaga, et al.
Gut|September 25, 2016
BCL-2 system analysis identifies high-risk colorectal cancer patientsAndreas U Lindner, Manuela Salvucci, Clare Morgan, et al.
Biorxiv : the Preprint Server for Biology|October 3, 2025
HIV Env trimers elicit NHP apex cross-neutralizing antibodies mimicking human bNAbsJavier Guenaga, Monika Adori, Shridhar Bale, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2005
Molecular study of malignant gliomas treated with epidermal growth factor receptor inhibitors: tissue analysis from North American Brain Tumor Consortium Trials 01-03 and 00-01Andrew B Lassman, Michael R Rossi, Jeffrey J Raizer, et al.
The Lancet. Gastroenterology & Hepatology|September 4, 2019
Aspirin as an adjuvant treatment for cancer: feasibility results from the Add-Aspirin randomised trialNalinie Joharatnam-Hogan, Fay Cafferty, Richard Hubner, et al.
Nature|April 29, 2026
Vaccination generates broadly cross-neutralizing antibodies to the HIV Env apexJavier Guenaga, Monika Ádori, Shridhar Bale, et al.
Immunity|April 13, 2016
Key gp120 Glycans Pose Roadblocks to the Rapid Development of VRC01-Class Antibodies in an HIV-1-Infected Chinese DonorLeopold Kong, Bin Ju, Yajing Chen, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 12, 2013
Implementing genomic medicine in the clinic: the future is hereTeri A Manolio, Rex L Chisholm, Brad Ozenberger, et al.
Pageof 27

Showing results (241-250 of 261) with videos related to

Sort By:
Pageof 27
The Journal of Clinical Investigation|June 4, 2014
Abnormal B cell memory subsets dominate HIV-specific responses in infected individualsLela Kardava, Susan Moir, Naisha Shah, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 23, 2012
Patient selection for oncology phase I trials: a multi-institutional study of prognostic factorsDavid Olmos, Roger P A'hern, Silvia Marsoni, et al.
NPJ Vaccines|August 20, 2025
Accelerated cGMP production of near-native HIV-1 Env trimers following electroporation transfection and immunogenicity analysisShridhar Bale, Elena Gustchina, Javier Guenaga, et al.
Gut|September 25, 2016
BCL-2 system analysis identifies high-risk colorectal cancer patientsAndreas U Lindner, Manuela Salvucci, Clare Morgan, et al.
Biorxiv : the Preprint Server for Biology|October 3, 2025
HIV Env trimers elicit NHP apex cross-neutralizing antibodies mimicking human bNAbsJavier Guenaga, Monika Adori, Shridhar Bale, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2005
Molecular study of malignant gliomas treated with epidermal growth factor receptor inhibitors: tissue analysis from North American Brain Tumor Consortium Trials 01-03 and 00-01Andrew B Lassman, Michael R Rossi, Jeffrey J Raizer, et al.
The Lancet. Gastroenterology & Hepatology|September 4, 2019
Aspirin as an adjuvant treatment for cancer: feasibility results from the Add-Aspirin randomised trialNalinie Joharatnam-Hogan, Fay Cafferty, Richard Hubner, et al.
Nature|April 29, 2026
Vaccination generates broadly cross-neutralizing antibodies to the HIV Env apexJavier Guenaga, Monika Ádori, Shridhar Bale, et al.
Immunity|April 13, 2016
Key gp120 Glycans Pose Roadblocks to the Rapid Development of VRC01-Class Antibodies in an HIV-1-Infected Chinese DonorLeopold Kong, Bin Ju, Yajing Chen, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 12, 2013
Implementing genomic medicine in the clinic: the future is hereTeri A Manolio, Rex L Chisholm, Brad Ozenberger, et al.
Pageof 27